Pharma Profits
-
The TRIPs waiver and India: A misadventure and a compromise in Geneva by the government
-
United States is approving drugs by the dozen. Why is it worrying Indian pharma companies?
-
India’s oldest drugmaker used some classic management tips to turn profitable after 64 years
-
World's poorest countries allowed to keep copying patent-protected drugs